|1.||Yang, Xuesong: 1 article (01/2007)|
|2.||Zhang, Zhenbo: 1 article (01/2007)|
|3.||Wang, Xiaoqi: 1 article (01/2007)|
|4.||Liu, Yuejian: 1 article (01/2007)|
|5.||Jia, Shuang: 1 article (01/2007)|
|6.||Yan, Qiu: 1 article (01/2007)|
|7.||Leusen, Jeanette H W: 1 article (06/2006)|
|8.||Golovkin, Maxim: 1 article (06/2006)|
|9.||Glogowska, Magdalena: 1 article (06/2006)|
|10.||van der Linden, Joke: 1 article (06/2006)|
03/01/1991 - "Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide."
01/01/2007 - "Lewis Y oligosaccharide has a terminal alpha1,3-linked fucose residue and elevation of Lewis Y level is seen in many epithelial cancers. "
12/10/1997 - "In addition, purified Le(y) glycolipid from canine intestine augmented the procoagulant activity of CCA-1p, and this augmentation also could be inhibited by FS01 MAb. We conclude that Le(y) glycolipid is a co-factor for the procoagulant activity derived from cancer cells."
12/10/1997 - "Le(y) glycolipid acts as a co-factor for tumor procoagulant activity."
05/01/1996 - "The murine monoclonal antibody BR55-2 is directed against the tumor-associated antigen Lewis Y oligosaccharide. "
|2.||Colorectal Neoplasms (Colorectal Cancer)
|1.||Immunoglobulin G (IgG)
|4.||Complement System Proteins (Complement)